Works matching IS 02724391 AND DT 2023 AND VI 84 AND IP 4

Results: 11

Involvement of matrix metalloproteinase 1 and urokinase‐type plasminogen activator in the PKCα‐p38 MAPK pathway‐mediated progression of human liver cancer cells.

Published in:

Drug Development Research, 2023, v. 84, n. 4, p. 767, doi. 10.1002/ddr.22057

By:

Ye, Je‐Chiuan;
Hsieh, Yih‐Shou;
Chen, Pei‐Ni;
Liu, Jer‐Yuh;
Hsieh, Yi‐Hsien

Publication type:

Article

Recent advances in the tumor‐penetrating peptide internalizing RGD for cancer treatment and diagnosis.

Published in:

Drug Development Research, 2023, v. 84, n. 4, p. 654, doi. 10.1002/ddr.22056

By:

Qian, Jing;
Zhou, Sheng;
Lin, Peng;
Lei, Jin;
Zheng, Shiqi;
Xu, Wenmang;
Wang, Yuanyuan;
Gao, Ziran;
Yang, Julun

Publication type:

Article

Proteolysis Targeting Chimera (PROTAC) as a promising novel therapeutic modality for the treatment of triple‐negative breast cancer (TNBC).

Published in:

Drug Development Research, 2023, v. 84, n. 4, p. 629, doi. 10.1002/ddr.22055

By:

Dogheim, Gaidaa M.;
Amralla, Mohamed T.

Publication type:

Article

Thieno[2,3‐c]isoquinolines: A novel chemotype of antiproliferative agents inducing cellular apoptosis while targeting the G2/M phase and Tubulin.

Published in:

Drug Development Research, 2023, v. 84, n. 4, p. 747, doi. 10.1002/ddr.22054

By:

Marae, Islam S.;
Maklad, Raed M.;
Samir, Safia;
Bakhite, Etify A.;
Sharmoukh, Walid

Publication type:

Article

Advances in natural small molecules on pretranslational regulation of gluconeogenesis.

Published in:

Drug Development Research, 2023, v. 84, n. 4, p. 613, doi. 10.1002/ddr.22053

By:

Wu, Xiaoran;
Chen, Sunhui

Publication type:

Article

Cinepazide maleate promotes recovery from spinal cord injury by inhibiting inflammation and prolonging neuronal survival.

Published in:

Drug Development Research, 2023, v. 84, n. 4, p. 736, doi. 10.1002/ddr.22052

By:

Li, Dadi;
Zhao, Shuxian;
Zhu, Bin;
Zhao, Wanmin;
Ding, Ya;
Li, Xuejun;
Fu, Donglin;
Yu, Haiyang;
Wang, Baogui;
Pan, Tan

Publication type:

Article

Combination of chemotherapy and gaseous signaling molecular therapy: Novel β‐elemene nitric oxide donor derivatives against leukemia.

Published in:

Drug Development Research, 2023, v. 84, n. 4, p. 718, doi. 10.1002/ddr.22051

By:

Zhu, Junlong;
Jiang, Xiaoying;
Luo, Xinyu;
Zhao, Rui;
Li, Junjie;
Cai, Hong;
Ye, Xiang‐Yang;
Bai, Renren;
Xie, Tian

Publication type:

Article

Design, synthesis, and biological evaluation of pleuromutilin derivatives containing 1,2,4‐triazole linker.

Published in:

Drug Development Research, 2023, v. 84, n. 4, p. 703, doi. 10.1002/ddr.22050

By:

Zhou, Zi‐Dan;
Hu, Yu‐Han;
Wang, Qi;
Xu, Heng;
Xi, Gao‐Lei;
Liu, Yan;
Gu, Liang;
Jin, Zhen;
Tang, You‐Zhi

Publication type:

Article

Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffold.

Published in:

Drug Development Research, 2023, v. 84, n. 4, p. 681, doi. 10.1002/ddr.22049

By:

Huwaimel, Bader I.;
Jonnalagadda, Sravan K.;
Jonnalagadda, Shirisha;
Kumari, Shikha;
Nocentini, Alessio;
Supuran, Claudiu T.;
Trippier, Paul C.

Publication type:

Article

Issue Information.

Published in:: Drug Development Research, 2023, v. 84, n. 4, p. 611, doi. 10.1002/ddr.21946
Publication type:: Article

Discovery and Characterization of Novel Naphthalimide Analogs as Potent Multitargeted Directed Ligands against Alzheimer's Disease.

Published in:

Drug Development Research, 2023, v. 84, n. 4, p. 671, doi. 10.1002/ddr.21708

By:

Gao, Jie;
Chapman, James

Publication type:

Article